Figure 1
From: Modafinil treatment modulates functional connectivity in stroke survivors with severe fatigue
Flowchart of the MRI component of the modafinil in debilitating fatigue (MIDAS) trial. (a) After screening for eligibility, patients were enrolled to the study and randomized to either the modafinil treatment arm or the placebo treatment arm. The first six-week treatment period was followed by a one-week washout period after which crossover occurred in which patients received the alternative treatment to their allocation. (b) Number of included scans per analysis.
